Combining Sputnik V and AstraZeneca Vaccines Showed No Side Effects: RDIF

Preliminary effects of a small-scale trial wherein the first and 2nd doses of COVID-19 vaccines of Sputnik V and AstraZeneca have been administered have revealed that the exercise offered significant protection towards the disease and posed no threat of negative aspect effects.


In a legit statement, the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund that is accountable for Sputnik V’s global marketing, stated the trial concerned 50 volunteers and become held in Azerbaijan. RDIF will put up the distinct effects of the trial, which includes the data on the immune response generated by combining each vaccine, next month.

ALSO, READ

Careem Bags Three Awards Including ‘Most Innovated App’ at Pakistan Digital Awards ‘21

The Coronavirus vaccines of Sputnik V and AstraZeneca are based on viral vectors wherein a first dose is followed by a booster shot. Such vaccines use innocent changed viruses as vehicles, to hold genetic facts that facilitate the body to build immunity against future infections.


Sputnik V, which was developed by Moscow’s Gamaleya Research Institute, is based on adenovirus kind 26 while AstraZeneca, which become advanced by Oxford University, is based on chimpanzee adenovirus vector.

Post a Comment

Previous Post Next Post
Close[x]